Paper36738424
Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study.
Huang SP and 4 others. Rheumatol Ther, 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study. Papers, record 36738424. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36738424
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GSK study 215295 | GSK | PubMed |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21584945 | A structured literature review of the direct costs of adult systemic lupus erythematosus in the US. | Arthritis Care Res (Hoboken) | 2011 | https://conductscience.org/library/papers/21584945 | PubMed |
| 2 | 28968809 | The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. | Rheumatology (Oxford) | 2017 | https://conductscience.org/library/papers/28968809 | PubMed |
| 3 | 24573911 | Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes. | Appl Health Econ Health Policy | 2014 | https://conductscience.org/library/papers/24573911 | PubMed |
| 4 | 26342222 | The frequency and outcome of lupus nephritis: results from an international inception cohort study. | Rheumatology (Oxford) | 2016 | https://conductscience.org/library/papers/26342222 | PubMed |
| 5 | 32571142 | Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. | Lupus | 2020 | https://conductscience.org/library/papers/32571142 | PubMed |
| 6 | 30661724 | Update on the Native Kidney Biopsy: Core Curriculum 2019. | Am J Kidney Dis | 2019 | https://conductscience.org/library/papers/30661724 | PubMed |
| 7 | 11953977 | Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. | Arthritis Rheum | 2002 | https://conductscience.org/library/papers/11953977 | PubMed |
| 8 | 32531505 | The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States. | Semin Arthritis Rheum | 2020 | https://conductscience.org/library/papers/32531505 | PubMed |
| 9 | 26815601 | Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis. | Arthritis Rheumatol | 2016 | https://conductscience.org/library/papers/26815601 | PubMed |
| 10 | 31784790 | Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores. | Rheumatol Int | 2020 | https://conductscience.org/library/papers/31784790 | PubMed |
| 11 | 32220834 | 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. | Ann Rheum Dis | 2020 | https://conductscience.org/library/papers/32220834 | PubMed |
| 12 | 21159829 | Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis. | J Rheumatol | 2011 | https://conductscience.org/library/papers/21159829 | PubMed |
| 13 | 28259425 | Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus. | Semin Arthritis Rheum | 2017 | https://conductscience.org/library/papers/28259425 | PubMed |
| 14 | 26471017 | Lupus nephritis: an update. | Clin Exp Nephrol | 2016 | https://conductscience.org/library/papers/26471017 | PubMed |
| 15 | 28059018 | Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry. | Lupus | 2017 | https://conductscience.org/library/papers/28059018 | PubMed |
| 16 | 23147758 | Diagnosis and treatment of lupus nephritis flares--an update. | Nat Rev Nephrol | 2012 | https://conductscience.org/library/papers/23147758 | PubMed |
| 17 | 32611669 | Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States. | J Rheumatol | 2021 | https://conductscience.org/library/papers/32611669 | PubMed |
| 18 | 22523116 | Survival analysis and causes of mortality in patients with lupus nephritis. | Nephrol Dial Transplant | 2012 | https://conductscience.org/library/papers/22523116 | PubMed |
| 19 | 21148601 | International consensus for a definition of disease flare in lupus. | Lupus | 2011 | https://conductscience.org/library/papers/21148601 | PubMed |
| 20 | 36038160 | Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus Cohort. | Lupus Sci Med | 2022 | https://conductscience.org/library/papers/36038160 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42257855 | Targeting FcRn for immunomodulation: a promising therapy in autoimmune inflammatory rheumatic diseases. | Inflamm Res | 2026 | https://conductscience.org/library/papers/42257855 | PubMed |
| 42171925 | A case of lupus nephritis achieving early remission using a treatment protocol similar to the AURORA trial with voclosporin and successfully discontinuing corticosteroids early. | CEN Case Rep | 2026 | https://conductscience.org/library/papers/42171925 | PubMed |
| 42110055 | The Price of Remission: Modeling the Total Financial Burden, Quality-of-Life Impairment, and Healthcare Dependence in Lupus Compared With Chimeric Antigen Receptor (CAR) T-cell Therapy. | Cureus | 2026 | https://conductscience.org/library/papers/42110055 | PubMed |
| 40528076 | Clinical Outcomes of Patients with SLE Treated with Belimumab, Without Versus With Prior Immunosuppressant Use: a US Claims Database Study. | Rheumatol Ther | 2025 | https://conductscience.org/library/papers/40528076 | PubMed |
| 39150646 | The Role of Dental-derived Stem Cell-based Therapy and Their Derived Extracellular Vesicles in Post-COVID-19 Syndrome-induced Tissue Damage. | Stem Cell Rev Rep | 2024 | https://conductscience.org/library/papers/39150646 | PubMed |
| 37852670 | Association of patient copayment and medication adherence in systemic lupus erythematosus. | Lupus Sci Med | 2023 | https://conductscience.org/library/papers/37852670 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36738424
GET https://conductscience.org/api/papers/v1/36738424/references?page=2